Cardiac risk assessment before the use of stimulant medications in children and youth-Reference-Cited by-同舟云学术

Cardiac risk assessment before the use of stimulant medications in children and youth

Published:2009-11 Issue:9 Volume:14 Page:579-585
ISSN:1205-7088
Container-title:Paediatrics & Child Health
language:en
Short-container-title:

Author:

Bélanger SA,Warren AE,Hamilton RM,Gray C,Gow RM,Sanatani S,Côté J-M,FRCPC J Lougheed,LeBlanc J,Martin S,Miles B,Mitchell C,Gorman DA,Weiss M,Schachar R

Publisher

Oxford University Press (OUP)

Subject

Pediatrics, Perinatology and Child Health

Link

http://academic.oup.com/pch/article-pdf/14/9/579/11188656/pch14579.pdf

Reference39 articles.

1. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association;Goldman;JAMA,1998

2. Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder;American Academy of Pediatrics, Subcommittee of Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement;Pediatrics,2001

3. Health Canada Updating of Product Monograph of Attention Deficit Hyperactivity Disorder (ADHD) Drugs – For Health Professionals (Version current at August 10, 2009).

4. US Food and Drug Administration, Drug Safety and Risk Management Advisory Committee (Version current at August 10, 2009).

5. Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing;Vetter;Circulation,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dikkat Eksikliği Hiperaktivite Bozukluğu İle Otonom Sinir Sisteminin İlişkisi: Bir Güncelleme;Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry;2022-06-30

2. New Formulations of Stimulants: An Update for Clinicians;Journal of Child and Adolescent Psychopharmacology;2019-06-01

3. ADHD in children and youth: Part 2—Treatment;Paediatrics & Child Health;2018-10-24

4. Canadian Guidelines on Pharmacotherapy for Disruptive and Aggressive Behaviour in Children and Adolescents with Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, or Conduct Disorder;The Canadian Journal of Psychiatry;2015-02

5. Risques cardiovasculaires et conduite à tenir dans le traitement du trouble déficit de l’attention/hyperactivité avec le méthylphénidate;Archives de Pédiatrie;2014-01